加药
医学
指南
风险因素
重症监护医学
安全监测
急诊医学
内科学
生物信息学
生物
病理
作者
Lucie Sikes,Kipson Charles,Abigail Antigua,Rima Patel,Selina Imboywa,Pheba Cherian
出处
期刊:HCA healthcare journal of medicine
[HCA Healthcare]
日期:2023-04-28
卷期号:4 (2)
标识
DOI:10.36518/2689-0216.1464
摘要
Monitoring anti-factor Xa levels is a controversial topic in the inpatient setting due to resource utilization and unclear conditional guideline recommendations regarding this practice. Enoxaparin dosing in certain high-risk patient populations such as those with low body weight, obesity, renal insufficiency, and pregnancy has not been determined. The objective of this review was to assess the safety and efficacy of enoxaparin monitoring via anti-factor Xa levels in high-risk patient populations.
科研通智能强力驱动
Strongly Powered by AbleSci AI